Cargando…
Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: a case series
OBJECTIVE: To report the successful use of lisdexamfetamine in the management of narcolepsy. METHODS: Five narcoleptic patients received lisdexamfetamine, at different dosages and for different periods, for management of excessive daytime sleepiness and weight control. RESULTS: All patients experien...
Autores principales: | Aguilar, Ana C., Frange, Cristina, Pimentel Filho, Lucio H., Reis, Maria J., Tufik, Sergio, Coelho, Fernando M.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Psiquiatria
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236164/ https://www.ncbi.nlm.nih.gov/pubmed/31859793 http://dx.doi.org/10.1590/1516-4446-2019-0544 |
Ejemplares similares
-
Effects of childhood trauma on BDNF and TBARS during crack-cocaine withdrawal
por: Sordi, Anne O., et al.
Publicado: (2019) -
Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility
por: Guevarra, Jay T, et al.
Publicado: (2020) -
Pharmacological Interventions for Excessive Daytime Sleepiness in Adults with Narcolepsy: A Systematic Review and Network Meta-Analysis
por: Chien, Po-Yu, et al.
Publicado: (2022) -
Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials
por: Meskill, Gerard J., et al.
Publicado: (2021) -
Excessive Daytime Sleepiness in Parkinson’s Disease
por: Liu, Hanshu, et al.
Publicado: (2022)